Fingerprint
Dive into the research topics of 'NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma
Patricia C. Galipeau, Xiaohong Li, Patricia L. Blount, Carlo C. Maley, Carissa A. Sanchez, Robert D. Odze, Kamran Ayub, Peter S. Rabinovitch, Thomas L. Vaughan, Brian J. Reid
Research output: Contribution to journal › Article › peer-review
213
Scopus
citations